Alopecia androgenetica
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Men between 18 and 41 years of age with androgenetic alopecia (male pattern) in state of Hamilton II-V. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Thyroid disease, Iron-deficiency, Androgenetic alopecia (female pattern), Diffuse alopecia, Alopecia areata, Drugs that cause hair loss.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Investigation whether Finasteride 1mg is more effective than Minoxidil 5%.;Secondary Objective: Investigation whether Finasteride 1mg + Minoxidil 5% are more effective than the respective monotherapy;Primary end point(s): Investigation whether Finasteride 1mg is more efficient than Minoxidil 5% in hair count and increase of anagen hair in a long-time treatment . | — |
Countries
Germany